AstraZeneca(AZN) - 2024 Q3 - Earnings Call Transcript

AstraZeneca PLC (NASDAQ:AZN) Q3 2024 Earnings Conference Call November 12, 2024 9:00 AM ET Company Participants Andy Barnett - Head, Investor Relations Pascal Soriot - Executive Director and CEO Aradhana Sarin - Executive Director and CFO Dave Fredrickson - Executive Vice President, Oncology Business Susan Galbraith - Executive Vice President, Oncology Research and Development Ruud Dobber - Executive Vice President and President, BioPharmaceuticals Sharon Barr - Executive Vice President, BioPharmaceuticals ...